H. Lundbeck A/S (HLUBF)
8.35
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
H. Lundbeck Price : 8.35 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 8.35 | 8.35 | 8.35 | 8.35 | 0.000 |
| Nov 12, 2026 | 8.35 | 8.35 | 8.35 | 8.35 | 150.00 |
| Nov 11, 2026 | 7.94 | 7.94 | 7.94 | 7.94 | 0.000 |
| Nov 10, 2026 | 7.94 | 7.94 | 7.94 | 7.94 | 0.000 |
| Nov 09, 2026 | 7.94 | 7.94 | 7.94 | 7.94 | 141.00 |
| Nov 06, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Nov 05, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 1.000 |
| Nov 04, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Nov 03, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Nov 02, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 30, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 29, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 28, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 27, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 26, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 15.00 |
| Oct 23, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 1.000 |
| Oct 22, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 21, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 20, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 19, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 16, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 15, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 14, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 13, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
| Oct 12, 2026 | 6.85 | 6.85 | 6.85 | 6.85 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 41.60 |
| ALK-Abello A/S | 36.50 |
| AstraZeneca PLC | 183.90 |
| ANI Pharmaceuticals, Inc. | 70.94 |
| Corcept Therapeutics, Inc. | 69.22 |
Price Related Metrics
| PE Ratio | 13.17 |
| PS Ratio | 2.037 |
| PEG Ratio | 0.9861 |
| Price to Book Value | 1.930 |
| Price to Free Cash Flow | 11.52 |
| Earnings Yield | 7.59% |
| Market Cap | 8.284B |
| PEGY Ratio | 0.847 |
| Operating PE Ratio | 7.985 |
| Normalized PE Ratio | 12.31 |